Clinicopathological parameters | n | CircRNA_100,338 alteration in serum exosomes | P | |
---|---|---|---|---|
(Post/Pre)decrease group | (Post/Pre)increase group | |||
(<  1.0, n = 23) | (≥ 1.0, n = 16) | |||
Age | 39 | Â | Â | 0.688 |
  < 58 y | 18 | 10 | 8 |  |
  ≥ 58y | 21 | 13 | 8 |  |
Gender | 39 | Â | Â | 0.862 |
 Female | 14 | 8 | 6 |  |
 Male | 25 | 15 | 10 |  |
Viral hepatitis | 39 | Â | Â | 1.000 |
 Type B | 37 | 22 | 15 |  |
 Type B and C | 2 | 1 | 1 |  |
Cirrhosis | 39 | Â | Â | 0.677 |
 Yes | 33 | 19 | 14 |  |
 No | 6 | 4 | 2 |  |
AFP level | 39 | Â | Â | 0.939 |
  < 20 ng/mL | 10 | 6 | 4 |  |
  ≥ 20 ng/mL | 29 | 17 | 12 |  |
Satellite | 39 | Â | Â | 0.018 |
 Yes | 18 | 7 | 11 |  |
 No | 21 | 16 | 5 |  |
TNM stage | 39 | Â | Â | 0.022 |
 I-II | 19 | 15 | 4 |  |
 III-IVA | 20 | 8 | 12 |  |
Vascular invasion | 39 | Â | Â | 0.023 |
 Yes | 16 | 6 | 10 |  |
 No | 23 | 17 | 6 |  |
γ-Glutamyl transferase | 39 |  |  | 0.522 |
  < 51 units/L | 17 | 11 | 6 |  |
  ≥ 51 units/L | 22 | 12 | 10 |  |
Lung metastasis# | 39 | Â | Â | 0.004 |
 Yes | 13 | 3 | 10 |  |
 No | 26 | 20 | 6 |  |